首页>
外国专利>
Intrauterine fetal growth restriction - The biochemical rationale of treatment modalities including extraperitoneal transamniotic fetal supplements
Intrauterine fetal growth restriction - The biochemical rationale of treatment modalities including extraperitoneal transamniotic fetal supplements
展开▼
机译：宫内胎儿生长受限-治疗方法的生化原理，包括腹膜外透羊膜胎儿补品
展开▼
页面导航
摘要
著录项
相似文献
摘要
Intrauterine fetal growth restriction (IUGR) is an affliction of a disparaging spectrum, placental insufficiency being the major inciting pathology. The resultant fetal hypoglycemia is alleviated by intravenous hypertonic D-glucose 25-50% maternal supplements, by improving the Vmax of placental transfer for D-glucose, in accordance with Michaelis-Menten model of substrate transfer. Fetal normoglycemia so restored in turn surprisingly improves fetal hypoxia, hypercapnia, hyperlacticemia, acidosis, hypertriglyceridemia, oliguria/hydromnios, and the fetal nutrient/mineral/vitamin acquisition. The list being phenomenal can only convince an inquiring reader by a biochemical sojourn into the aquatic world of the fetus, herein described. Maternal carbohydrate-predominant IUGR diet with maximal amounts of vitamin/mineral supplements are highly beneficial. Transamniotic isotonic D-glucose supplements via minimally invasive suprapubic extraperitonial pelvic approach and amniotomy (Sumathi Paturu's technique), with a subcutaneously implanted pregnancy port (SIPP) catheter is the additional therapy advocated.
展开▼
